Clinical care incorporates the use of more than 20 FDA-approved injectable, oral and infusion maintenance immunotherapies for multiple sclerosis. Our program has been involved in drug studies leading to approval of many of these therapies. We also employ state-of-the-art symptomatic treatments, including four aminopyridine, intrathecal baclofen for spasticity and robotic therapy.
As a partner in MS Care-Center for Comprehensive and Coordinated Care with the National Multiple Sclerosis Society, our faculty members participate in investigational new drug studies, looking for improved treatments which will hopefully lead to a cure for this disease. Some trials are single-site studies at the IU School of Medicine and others are part of national and international multicenter consortiums. Faculty physicians also collaborate with basic scientists at the IU School of Medicine, and elsewhere, to investigate the underlying cause of multiple sclerosis and ways to monitor the disease.
Faculty and staff are involved in training medical students, residents, fellows, nurses and advanced care providers to care for multiple sclerosis patients and conduct research in multiple sclerosis.